$CYN
Cyngn Inc. Stock $cyn

$cyn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024020777 Filed on March 07, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$5.513K	$40.36K	$1.500M
YoY Change	-99.37%	-84.6%	472.52%
Cost Of Revenue	$113.8K	$100.6K	$1.222M
YoY Change	-81.55%	-46.16%	554.27%
Gross Profit	-$108.3K	-$60.23K	$277.7K
YoY Change	-142.27%	-180.11%	269.37%
Gross Profit Margin	-1963.78%	-149.23%	18.51%
Selling, General & Admin	$2.703M	$2.313M	$10.89M
YoY Change	-11.97%	-21.53%	8.99%
% of Gross Profit			3922.86%
Research & Development	$3.155M	$3.023M	$12.72M
YoY Change	4.11%	7.25%	34.16%
% of Gross Profit			4580.82%
Depreciation & Amortization	$225.6K	$253.9K	$961.3K
YoY Change	-1.07%	31.33%	58.92%
% of Gross Profit			346.18%
Operating Expenses	$3.155M	$5.336M	$12.72M
YoY Change	4.11%	-7.46%	34.16%
Operating Profit	-$5.966M	-$5.396M	-$23.35M
YoY Change	2.08%	-5.18%	20.34%
Interest Expense	$1.330K	$39.19K	$137.9K
YoY Change	-97.16%	-5.36%	212.68%
% of Operating Profit
Other Income/Expense, Net	-$3.720K	-$790.00	$534.7K
YoY Change	-101.72%	-100.77%	225.61%
Pretax Income	-$5.970M	-$5.358M	-$22.81M
YoY Change	6.06%	-3.4%	18.58%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$5.970M	-$5.358M	-$22.81M
YoY Change	6.06%	-3.4%	18.58%
Net Earnings / Revenue	-108290.93%	-13274.43%	-1520.75%
Basic Earnings Per Share	-$0.08		-$0.57
Diluted Earnings Per Share	-$0.08	-$0.11	-$0.57
COMMON SHARES
Basic Shares Outstanding	82.29M shares	41.80M shares	39.99M shares
Diluted Shares Outstanding	77.08M shares		39.99M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.771M	$8.154M	$8.154M
YoY Change	-71.86%	-63.92%	-63.92%
Cash & Equivalents	$2.200M	$3.592M	$3.592M
Short-Term Investments	$2.579M	$4.562M	$4.562M
Other Short-Term Assets	$55.11K	$9.526K	$1.316M
YoY Change	-96.02%	-99.19%	11.93%
Inventory	$70.28K
Prepaid Expenses	$437.9K	$385.5K
Receivables
Other Receivables	$763.6K	$765.7K
Total Short-Term Assets	$6.273M	$9.470M	$9.470M
YoY Change	-65.8%	-60.17%	-60.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.652M	$1.487M	$2.479M
YoY Change	32.16%	68.18%	97.5%
Goodwill
YoY Change
Intangibles	$1.045M	$1.084M
YoY Change	105.27%	129.23%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.519M	$3.563M	$3.563M
YoY Change	76.59%	106.18%	106.18%
TOTAL ASSETS
Total Short-Term Assets	$6.273M	$9.470M	$9.470M
Total Long-Term Assets	$3.519M	$3.563M	$3.563M
Total Assets	$9.792M	$13.03M	$13.03M
YoY Change	-51.84%	-48.9%	-48.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$248.7K	$197.0K	$197.0K
YoY Change	-43.94%	26.3%	26.3%
Accrued Expenses	$355.9K	$214.3K	$1.883M
YoY Change	274.69%	-24.31%	52.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.694M	$2.081M	$2.081M
YoY Change	85.31%	49.97%	49.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$127.6K	$317.3K	$317.3K
YoY Change
Total Long-Term Liabilities	$127.6K	$317.3K	$317.3K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.694M	$2.081M	$2.081M
Total Long-Term Liabilities	$127.6K	$317.3K	$317.3K
Total Liabilities	$1.821M	$2.398M	$2.398M
YoY Change	99.26%	72.84%	72.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$166.0M	-$160.0M
YoY Change	17.43%	17.88%
Common Stock	$884.00	$648.00
YoY Change	162.31%	92.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.600M	$4.600M
YoY Change	-71.11%	-61.98%
Treasury Stock Shares
Shareholders Equity	$7.971M	$10.64M	$10.64M
YoY Change
Total Liabilities & Shareholders Equity	$9.792M	$13.03M	$13.03M
YoY Change	-51.84%	-48.9%	-48.9%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$5.970M	-$5.358M	-$22.81M
YoY Change	6.06%	-3.4%	18.58%
Depreciation, Depletion And Amortization	$225.6K	$253.9K	$961.3K
YoY Change	-1.07%	31.33%	58.92%
Cash From Operating Activities	-$5.800M	-$5.038M	-$19.48M
YoY Change	7.86%	7.18%	19.5%
INVESTING ACTIVITIES
Capital Expenditures	$214.2K	$141.4K	$1.046M
YoY Change	-52.15%	-49.28%	13.88%
Acquisitions
YoY Change
Other Investing Activities	$2.003M	$134.4K	$7.408M
YoY Change	-37.4%	-98.64%	-159.59%
Cash From Investing Activities	$1.789M	-$7.000K	$6.362M
YoY Change	-35.0%	-100.07%	-147.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$16.18K
YoY Change			-100.09%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.652M	5.100M	$6.121M
YoY Change	38650.1%		-66.44%
NET CHANGE
Cash From Operating Activities	-$5.800M	-5.038M	-$19.48M
Cash From Investing Activities	$1.789M	-7.000K	$6.362M
Cash From Financing Activities	$2.652M	5.100M	$6.121M
Net Change In Cash	-$1.359M	55.24K	-$6.995M
YoY Change	-48.1%	-98.87%	-38.7%
FREE CASH FLOW
Cash From Operating Activities	-$5.800M	-$5.038M	-$19.48M
Capital Expenditures	$214.2K	$141.4K	$1.046M
Free Cash Flow	-$6.014M	-$5.179M	-$20.52M
YoY Change	3.25%	4.02%	19.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40932
CY2023	dei	Entity Registrant Name EntityRegistrantName	CYNGN INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2007094
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1015 O’Brien Dr
CY2023	dei	Local Phone Number LocalPhoneNumber	924-5905
CY2023	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.00001
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Menlo Park
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94025
CY2023	dei	City Area Code CityAreaCode	(650)
CY2023	dei	Trading Symbol TradingSymbol	CYN
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	19432847	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82287127	shares
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Location AuditorLocation	San Francisco, California
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3591623	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10536273	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	50000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	4561928	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	12064337	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1316426	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1126137	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9469977	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	23776747	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1486672	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	884000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	992292	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	371189	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1084415	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	473076	usd
CY2023Q4	us-gaap	Assets Assets	13033356	usd
CY2022Q4	us-gaap	Assets Assets	25505012	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	196963	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	155943	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1201142	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	854920	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	682718	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	376622	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2080823	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1387485	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	317344	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2398167	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1387485	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64773756	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64773756	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33684864	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33684864	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	648	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	337	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	170652160	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	159847229	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-160017619	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135730039	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10635189	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24117527	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13033356	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25505012	usd
CY2023	us-gaap	Revenues Revenues	1489317	usd
CY2022	us-gaap	Revenues Revenues	262000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1222321	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	186823	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12719983	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9481329	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10892955	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9994575	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	24835259	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	19662727	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-23345942	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-19400727	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	137887	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	44100	usd
CY2023	us-gaap	Other Income OtherIncome	396825	usd
CY2022	us-gaap	Other Income OtherIncome	120118	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	534712	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	164218	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22811230	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19236509	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39987864	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34947710	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	22247562	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	114169	usd
CY2022	cyngn	Issuance Of Common Stock And Pre Funded Warrants In Connection With The Private Placement Offering Net Of Offering Costs IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithThePrivatePlacementOfferingNetOfOfferingCosts	1857700	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	11989509	usd
CY2022	cyngn	Stock Issued During Period Value Issuance Of Common Stock Upon Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueIssuanceOfCommonStockUponExerciseOfPrefundedWarrants	2662	usd
CY2022	cyngn	Stock Issued During Period Value Issuance Of Common Warrants At Fair Value In Connection With The Private Placement StockIssuedDuringPeriodValueIssuanceOfCommonWarrantsAtFairValueInConnectionWithThePrivatePlacement	6132436	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2867698	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19236509	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24117527	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	8528	usd
CY2023	cyngn	Issuance Of Common Stock And Pre Funded Warrants In Connection With The Private Placement Offering Net Of Offering Costs IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithThePrivatePlacementOfferingNetOfOfferingCosts	618965	usd
CY2023	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	4380975	usd
CY2023	cyngn	Issuance Of Common Stock Atthemarket Equity Financing Net Of Offering Costs IssuanceOfCommonStockAtthemarketEquityFinancingNetOfOfferingCosts	97362	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1747468	usd
CY2023	cyngn	Stock Dividend Net Of Offering Costs StockDividendNetOfOfferingCosts	16182	usd
CY2023	cyngn	Stock Dividend Net Of Offering Costs Of16182 StockDividendNetOfOfferingCostsOf16182	-16182	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3208103	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22811230	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10635189	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22811230	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19236509	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	961281	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	604871	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3208103	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2867698	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	443392	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	90216	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1403049	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1425126	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	41020	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	43672	usd
CY2023	cyngn	Increase Decrease In Accrued Expenses And Other Current Liabilities IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities	969662	usd
CY2022	cyngn	Increase Decrease In Accrued Expenses And Other Current Liabilities IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities	936387	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19477605	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16299223	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1045822	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	918318	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	718711	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	456822	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	21573199	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	27000000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	29519000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	15025879	usd
CY2023	cyngn	Disposal Of Assets DisposalOfAssets	180898	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6362166	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13349261	usd
CY2023	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	1747468	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4380975	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	18121945	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2662	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-16182	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8528	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	114169	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6120789	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18238776	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6994650	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11409708	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10586273	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21995981	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3591623	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10586273	usd
CY2023	cyngn	Recognition Of Operating Lease Rightofuse And Operating Lease Liabilities RecognitionOfOperatingLeaseRightofuseAndOperatingLeaseLiabilities	1212760	usd
CY2022	cyngn	Recognition Of Operating Lease Rightofuse And Operating Lease Liabilities RecognitionOfOperatingLeaseRightofuseAndOperatingLeaseLiabilities	842292	usd
CY2023	cyngn	Stock Dividend StockDividend	1460126	usd
CY2023	cyngn	Incurred Net Losses IncurredNetLosses	22800000	usd
CY2022	cyngn	Incurred Net Losses IncurredNetLosses	19200000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-160000000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135700000	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	19500000	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	16300000	usd
CY2023Q4	us-gaap	Cash Cash	3600000	usd
CY2023Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	4600000	usd
CY2022Q4	us-gaap	Cash Cash	10500000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	12100000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments include but are not limited to internal-use software and developed software to be sold, leased or marketed, warrants and share-based compensation. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates. </p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times exceeds federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash maintained with domestic financial institutions generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.</p>
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	3600000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	10500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P15Y
CY2022Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	100000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	30000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6451613	shares
CY2023Q4	cyngn	Advertising Costs AdvertisingCosts	413170	usd
CY2022Q4	cyngn	Advertising Costs AdvertisingCosts	194566	usd
CY2023	cyngn	Total Revenue Cost Percentage TotalRevenueCostPercentage	0.10	pure
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.584	pure
CY2023	us-gaap	Revenues Revenues	1500000	usd
CY2023Q4	us-gaap	Amount Of Deferred Costs Related To Long Term Contracts AmountOfDeferredCostsRelatedToLongTermContracts	0	usd
CY2022Q4	us-gaap	Amount Of Deferred Costs Related To Long Term Contracts AmountOfDeferredCostsRelatedToLongTermContracts	114654	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4600000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	12100000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	66780	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	385474	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	706452	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	155729	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	141961	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	765697	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9526	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	210944	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1316426	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1126137	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2322009	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1407084	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	835337	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	523084	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1486672	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	884000	usd
CY2023	us-gaap	Depreciation Depreciation	312253	usd
CY2022	us-gaap	Depreciation Depreciation	137105	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	41250	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	0	usd
CY2023Q4	cyngn	Credit Card Payable CreditCardPayable	1103	usd
CY2022Q4	cyngn	Credit Card Payable CreditCardPayable	5194	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	214286	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	283118	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	985753	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	566608	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1201142	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	854920	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	60000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	722641	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	301100	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1023741	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	31449	usd
CY2023Q4	us-gaap	Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions	992292	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y5M1D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y8M1D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0305	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.044	pure
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	601913	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	517296	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	591656	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	453103	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1227532	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	63117	usd
CY2023	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-50000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	30000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1084415	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	508821	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	35745	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	473076	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	27372	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14662	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-50000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-30000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33684864	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33684864	shares
CY2023Q4	cyngn	Aggregate Shares AggregateShares	33333333	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	21866600	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.00001
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.15
CY2023Q4	cyngn	Gross Proceeds GrossProceeds	5000000	usd
CY2023Q4	cyngn	Other Direct Costs OtherDirectCosts	500000	usd
CY2023Q2	cyngn	Gross Proceeds Percentage GrossProceedsPercentage	0.03	pure
CY2023Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	3731524	usd
CY2023	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	36897	usd
CY2023	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	60465	usd
CY2023	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	3790322	shares
CY2023	cyngn	Issuance Of Common Stock Upon Exercise Of Prefunded Warrantsin Shares IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares	2661291	shares
CY2023	cyngn	Common Warrants CommonWarrants	6451613	shares
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	3.09
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.98
CY2023	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	2.71
CY2023Q1	cyngn	Gross Proceeds GrossProceeds	20000000	usd
CY2023Q4	cyngn	Warrants Outstanding WarrantsOutstanding	7236776	shares
CY2023	cyngn	Fair Value FairValue	6916078	usd
CY2023Q4	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.10	pure
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22811230	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19236509	usd
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39987864	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	34947710	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	The resulting fair value is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual term of ten years.
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.05	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	1500000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	17000000	shares
CY2023	cyngn	Issuance Of Common Stock IssuanceOfCommonStock	700000	usd
CY2022	cyngn	Issuance Of Common Stock IssuanceOfCommonStock	3600000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14715110	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.23
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2571013	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4519000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.67
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	25750	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.33
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	16403	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1705107	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.66
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17503253	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.04
CY2023	cyngn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P7Y4M13D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	42527	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	17503253	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.04
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y4M13D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	42527	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	8531483	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.96
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y8M1D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	42527	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.55
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.74
CY2023Q4	us-gaap	Share Price SharePrice	1.02
CY2022Q4	us-gaap	Share Price SharePrice	1.76
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y18D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0363	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.026	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5274	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.403	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3208103	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2867698	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	7300000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-22812381	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-19236289	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1150	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-220	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22811231	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19236509	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4790600	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4039453	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-815249	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-415015	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	276371	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	204047	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1071338	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	673881	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-142058	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	22081	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5517860	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4516446	usd
CY2023	cyngn	Income Tax Reconciliation Change In Deferred Tax Assets Deferredtrueup IncomeTaxReconciliationChangeInDeferredTaxAssetsDeferredtrueup	1320182	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-247773	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	369874	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-47395	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	15901	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	32935845	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30186203	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	5938775	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4867437	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1192900	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1303262	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	67200	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	61295	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	410323	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	654860	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	146482	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	69486	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	245790	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	87233	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	3905973	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	1969682	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6876	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1496	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	44850164	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	39200954	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	44606284	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39088423	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	243880	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	112531	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Regulatory Assets And Liabilities DeferredTaxLiabilitiesRegulatoryAssetsAndLiabilities	243880	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Regulatory Assets And Liabilities DeferredTaxLiabilitiesRegulatoryAssetsAndLiabilities	85975	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-26556	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	243880	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	112531	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5517861	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4516446	usd
CY2023	us-gaap	Subsidiary Or Equity Method Investee Cumulative Percentage Ownership After All Transactions SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions	0.50	pure
CY2023	us-gaap	Other Expenses OtherExpenses	763624	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2086044	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1797238	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	459145	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	288806	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2545189	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2086044	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2545189	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1978807	shares
CY2023	cyngn	Net Proceeds NetProceeds	477734	usd
CY2023	us-gaap	Payments For Commissions PaymentsForCommissions	9750	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34947710	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39987864	shares
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022	cyngn	Disposal Of Assets DisposalOfAssets		usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023	cyngn	Cash Paid During The Year For Income Taxes CashPaidDuringTheYearForIncomeTaxes		usd
CY2022	cyngn	Cash Paid During The Year For Income Taxes CashPaidDuringTheYearForIncomeTaxes		usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage		pure
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet		usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet		usd
CY2023Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023Q4	us-gaap	Salvage And Subrogation Recoveries Value SalvageAndSubrogationRecoveriesValue		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34947710	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39987864	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2023Q4	cyngn	Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueGranted		usd
CY2023Q4	cyngn	Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value Cancelledforfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueCancelledforfeited		usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential		usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential		usd
CY2022	cyngn	Income Tax Reconciliation Change In Deferred Tax Assets Deferredtrueup IncomeTaxReconciliationChangeInDeferredTaxAssetsDeferredtrueup		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense		usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001874097

Files In Submission

Name	View Source	Status
0001213900-24-020777-index-headers.html	Edgar Link	pending
0001213900-24-020777-index.html	Edgar Link	pending
0001213900-24-020777.txt	Edgar Link	pending
R34.htm	Edgar Link	pending
0001213900-24-020777-xbrl.zip	Edgar Link	pending
cyngn-20231231.xsd	Edgar Link	pending
f10k2023ex10-17_cyngninc.htm	Edgar Link	pending
f10k2023ex21-1_cyngninc.htm	Edgar Link	pending
f10k2023ex23-1_cyngninc.htm	Edgar Link	pending
f10k2023ex31-1_cyngninc.htm	Edgar Link	pending
f10k2023ex31-2_cyngninc.htm	Edgar Link	pending
f10k2023ex32-1_cyngninc.htm	Edgar Link	pending
f10k2023ex97_cyngninc.htm	Edgar Link	pending
f10k2023_cyngninc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
cyngn-20231231_def.xml	Edgar Link	unprocessable
f10k2023_cyngninc_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cyngn-20231231_lab.xml	Edgar Link	unprocessable
cyngn-20231231_cal.xml	Edgar Link	unprocessable
cyngn-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYN
Cyngn Inc. Stock $cyn

2024 Q1 Form 10-K Financial Statement

#000121390024020777 Filed on March 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYN Cyngn Inc. Stock $cyn

2024 Q1 Form 10-K Financial Statement

#000121390024020777 Filed on March 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYN
Cyngn Inc. Stock $cyn